Ligand validation:5AX0

OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLB is a Ligand Of Interest in 5AX0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5AX0_OLB_A_304	16%	77%	0.22	0.785	0.44	0.47	-	-	1	0	100%	1
5AX0_OLB_A_302	9%	80%	0.272	0.756	0.42	0.42	-	-	0	0	100%	1
5AX0_OLB_A_303	1%	77%	0.331	0.489	0.43	0.48	-	-	0	0	100%	1
5AX1_OLB_A_302	12%	79%	0.227	0.756	0.41	0.45	-	-	1	0	100%	1
5LX9_OLB_A_409	49%	93%	0.17	0.917	0.19	0.3	-	-	1	0	100%	0.64
4KPP_OLB_A_502	41%	46%	0.17	0.892	1.07	1.02	2	1	0	0	96%	0.96
6XLP_OLB_A_616	34%	61%	0.182	0.908	0.8	0.69	-	-	1	0	76%	0.76
5IUB_OLB_A_2421	34%	53%	0.166	0.898	0.93	0.89	2	1	0	0	72%	0.72
7AVN_OLB_B_314	33%	40%	0.105	0.863	1.2	1.18	1	1	3	0	56%	0.56

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.